Steve Schonfeld’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,548
Closed -$776K 2516
2024
Q2
$776K Buy
+11,548
New +$778K 0.01% 1304
2023
Q3
Sell
-12,200
Closed -$616K 2417
2023
Q2
$616K Buy
+12,200
New +$649K 0.01% 1138
2023
Q1
Sell
-55,000
Closed -$3.44M 2777
2022
Q4
$3.44M Buy
55,000
+2,100
+4% +$139K 0.03% 609
2022
Q3
$3.73M Buy
+52,900
New +$3.65M 0.03% 629
2022
Q1
Sell
-28,600
Closed -$1.6M 2993
2021
Q4
$1.6M Buy
+28,600
New +$1.75M 0.01% 758
2021
Q3
Sell
-13,425
Closed -$851K 2542
2021
Q2
$851K Buy
+13,425
New +$792K 0.01% 986
2021
Q1
Sell
-9,800
Closed -$489K 2185
2020
Q4
$489K Sell
9,800
-29,316
-75% -$1.38M 0.01% 1045
2020
Q3
$2M Sell
39,116
-8,180
-17% -$341K 0.04% 511
2020
Q2
$1.66M Buy
+47,296
New +$1.63M 0.04% 456
2020
Q1
Sell
-99,700
Closed -$2.76M 1600
2019
Q4
$2.76M Buy
99,700
+52,600
+112% +$1.26M 0.07% 288
2019
Q3
$1.27M Buy
47,100
+7,200
+18% +$251K 0.04% 414
2019
Q2
$1.63M Buy
39,900
+15,000
+60% +$422K 0.06% 334
2019
Q1
$596K Sell
24,900
-3,900
-14% -$70.7K 0.02% 646
2018
Q4
$435K Buy
+28,800
New +$429K 0.02% 705

Other funds holding AXNX

Steve Schonfeld's AXNX Position: Q3 2024 in Review

Steve Schonfeld sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2024, closing a stake of 11,548 shares — an estimated $776K sold.

Steve Schonfeld first reported a position in AXNX in Q4 2018 and held it in 14 quarters. The position peaked at $3.73M in Q3 2022. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Steve Schonfeld reported no remaining Axonics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Steve Schonfeld sold 11,548 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $776K.
  • Steve Schonfeld first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • Steve Schonfeld's Axonics, Inc. Common Stock position peaked at $3.73M in Q3 2022.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.